BRADLEY SENTELL: Open Payments
NPI 1841818812 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 55 payments from 14 companies in 2025. Trend: 2023 $108 · 2024 $152 · 2025 $1,240
Food & beverage: $1,156Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $205 |
| Janssen Biotech, Inc. | 6 | $153 |
| Celltrion USA Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 6 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| GENZYME CORPORATION | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Ardelyx, Inc. | 4 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| QOL Medical, LLC | 2 | $66 |
Products named: DUPIXENT, TREMFYA, ZYMFENTRA, REZDIFFRA, SKYRIZI, RINVOQ, IBSRELA, Sucraid.
Industry payments across SC — which companies pay providers there.
